Is SURY or MRK a better dividend investment in 2026?

SURY currently yields 21978.02% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SURY offers higher current income.

What is the dividend yield difference between SURY and MRK?

SURY has a forward dividend yield of 21978.02% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 21975.26 percentage points.

Home › Compare › SURY vs MRK

SURY vs MRK: Dividend Comparison 2026

SURY yields 21978.02% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SURY wins by $133883659849018736640.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SURY

● Live price

21978.02%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$133883659849018736640.00M

Annual income

$132,695,959,531,130,540,000,000,000.00

Full SURY calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SURY vs MRK

📍 SURY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SURY	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SURY + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SURY pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SURY

Annual income on $10K today (after 15% tax)

$1,868,131.87/yr

After 10yr DRIP, annual income (after tax)

$112,791,565,601,460,960,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SURY beats the other by $112,791,565,601,460,960,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SURY + MRK for your $10,000?

SURY: 50%MRK: 50%

100% MRK50/50100% SURY

Portfolio after 10yr

$66941829924509368320.00M

Annual income

$66,347,979,765,565,270,000,000,000.00/yr

Blended yield

99.11%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SURY

No analyst data

Altman Z

3.8

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SURY buys

MRK buys

No recent congressional trades found for SURY or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSURYMRK

Forward yield	21978.02% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$133883659849018736640.00M ✓	$56.8K
Annual income after 10y	$132,695,959,531,130,540,000,000,000.00 ✓	$9,798.13
Total dividends collected	$133805353031208288256.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SURY vs MRK ($10,000, DRIP)

Year	SURY Portfolio	SURY Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$2,208,502	$2,197,802.20	$11,206	$366.19	+$2.20M → SURY
2	$455,994,030	$453,630,933.10	$12,650	$502.35	+$455.98M → SURY
3	$88,022,605,054	$87,534,691,441.48	$14,407	$694.19	+$88022.59M → SURY
4	$15,885,978,830,053	$15,791,794,642,644.97	$16,585	$967.82	+$15885978.81M → SURY
5	$2,680,588,588,147,197	$2,663,590,590,799,040.50	$19,342	$1,363.89	+$2680588588.13M → SURY
6	$422,917,156,433,403,260	$420,048,926,644,085,700.00	$22,913	$1,947.19	+$422917156433.38M → SURY
7	$62,388,248,501,996,870,000	$61,935,727,144,613,134,000.00	$27,662	$2,823.89	+$62388248501996.84M → SURY
8	$8,605,714,909,688,405,000,000	$8,538,959,483,791,268,000,000.00	$34,159	$4,173.35	+$8605714909688405.00M → SURY
9	$1,110,000,297,091,772,800,000,000	$1,100,792,182,138,406,200,000,000.00	$43,337	$6,308.80	+$1110000297091772800.00M → SURY
10	$133,883,659,849,018,740,000,000,000	$132,695,959,531,130,540,000,000,000.00	$56,776	$9,798.13	+$133883659849018736640.00M → SURY

SURY vs MRK: Complete Analysis 2026

SURY — Stock

Surya Oil and Gas Corp. focuses on acquiring traditional oil and gas opportunities and energy transition materials. It focuses on mining opportunities in copper, lithium, and gold, as well as other precious and rare earth metals. The company was formerly known as Cunningham Natural Resources Corp and changed its name to Surya Oil and Gas Corp. in July 2025. Surya Oil and Gas Corp. is based in Charleston, West Virginia. As of July 1, 2025, Surya Oil and Gas Corp. operates as a subsidiary of Aruna Holdings, LLC.

Full SURY Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SURY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SURY vs SCHD SURY vs JEPI SURY vs O SURY vs KO SURY vs MAIN SURY vs JNJ SURY vs ABBV SURY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.